Vireo Growth (VREOF) Gross Profit (2020 - 2026)
Vireo Growth's (VREOF) quarterly Gross Profit came in at $59.3 million in Q1 2026, up 378.23% year-on-year from $12.4 million in Q1 2025, and up 4.25% quarter-over-quarter from $56.9 million in Q4 2025.
Vireo Growth (VREOF) Gross Profit (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Gross Profit across 7 years of filings, most recently posting $59.3 million for Q1 2026.
- Gross Profit for Q1 2026 came in at $59.3 million, up 378.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $174.0 million (up 241.64% YoY), and the FY2025 annual result was $127.1 million, up 150.33% from the prior year.
- Gross Profit came in at $59.3 million for Q1 2026 at Vireo Growth, up from $56.9 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $59.3 million in Q1 2026 to a low of $2.5 million in Q1 2022.
- The 5-year median for Gross Profit is $12.3 million (2024), against an average of $18.4 million.
- Across the five-year window, Gross Profit slumped 55.68% in 2022 and surged 378.23% in 2026, its largest moves.
- Vireo Growth's Gross Profit stood at $8.5 million in 2022, then jumped by 41.57% to $12.1 million in 2023, then gained by 4.95% to $12.7 million in 2024, then surged by 349.59% to $56.9 million in 2025, then grew by 4.25% to $59.3 million in 2026.
- The last three Gross Profit figures came in at $59.3 million (Q1 2026), $56.9 million (Q4 2025), and $37.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.30 Mn |
| Mar 31, 2026 | 59.30 Mn |
| Dec 31, 2025 | 56.88 Mn |
| Dec 31, 2025 | 56.88 Mn |
| Sep 30, 2025 | 37.38 Mn |
| Sep 30, 2025 | 37.38 Mn |
| Jun 30, 2025 | 20.42 Mn |
| Jun 30, 2025 | 20.42 Mn |
| Mar 31, 2025 | 12.40 Mn |
| Mar 31, 2025 | 12.40 Mn |
| Dec 31, 2024 | 12.65 Mn |
| Dec 31, 2024 | 12.65 Mn |
| Sep 30, 2024 | 12.32 Mn |
| Sep 30, 2024 | 12.32 Mn |
| Jun 30, 2024 | 13.55 Mn |
| Jun 30, 2024 | 13.55 Mn |
| Mar 31, 2024 | 12.24 Mn |
| Mar 31, 2024 | 12.24 Mn |
| Dec 31, 2023 | 12.06 Mn |
| Dec 31, 2023 | 12.06 Mn |